Germany Pharmaceutical Pricing & Reimbursement Guide 2016 – Research and Markets
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.
This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Key Topics Covered:
1. HEALTHCARE SYSTEM
Facts & Figures
Market Indicators
Provision & Funding
Healthcare Services
Healthcare Reform
2. PRICING
Prescription Drugs
Early Benefit Assessments
Rebate Negotiations Following Early Benefit Assessments
Market Developments
Mandatory Rebates
Voluntary Discount Agreements
Generic Drugs
Mandatory Discounts
Voluntary Discount Agreements
Hospital Drugs
Pricing
Purchasing
Dispensing to Out-patients
OTC Drugs
Discounts
3. REIMBURSEMENT
Admission to Reimbursement
Non-prescription Drugs
Lifestyle Drugs
Minor Illnesses
Unproven Therapeutic Benefit, Medical Necessity or Economic Efficiency
Therapeutic Recommendations
Off-label Drugs
Negative List
Reimbursement Categories
Reimbursement Prices
Reference Price System
Hospital Reimbursement
Formularies
Funding
4. PHARMACOECONOMICS
Pharmacoeconomic Requirements
Early Benefit Assessments
Benefit Assessments
Cost-benefit Assessments
5. PRICE BUILD UP
Wholesalers
Margins
Discounts
Unit-dose Products
Background
Retail Pharmacies
Prescription Drugs
Non-Prescription Drugs
Parallel Import Quota
Background
Dispensing Doctors
Sales Tax
6. COST CONTAINMENT
Industry Paybacks
Promotional Costs
Advertising
Payments to Physicians
Patient Co-payments
GKV
PKV
Prescribing Controls
Binding Prescribing Guidelines
Prescribing Conditions for Drugs Subject to Early Benefit Assessments
Regional Prescribing Agreements
Disease Management Programmes
7. FUTURE DEVELOPMENTS
Outlook
Biosimilars Savings Potential
Parallel Import Dispensing Quota Controversy
8. NAMES & ADDRESSES
For more information about this report visit http://www.researchandmarkets.com/research/kp6m9s/ims
View source version on businesswire.com: http://www.businesswire.com/news/home/20161004005748/en/
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Fax (outside
Related Topics: Pharmaceuticals, Pharmacoeconomics
Source:
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News